Asimov
Asimov builds a mammalian synthetic biology platform—combining wet-lab tools, computer-aided design software, and machine learning—to program living cells for biologics and gene therapy development. It partners with biotech and pharmaceutical companies to design and optimize cell lines and manufacturing processes, offering software and R&D services around parts, circuits, and process development. Founded in 2017 and headquartered in Boston, it is privately held.
Open Positions at Asimov
1 open position
Help architect Kernel, Asimov’s software platform for designing and analyzing genetic systems. You’ll build production APIs and biological data models while working directly with scientists and synthetic biologists.
GraphQLPython
10 months ago